Literature DB >> 16758114

Characterization and in vitro cytotoxicity testing of ethanolamine-derived cadmium chelating agents.

Mikhail Zhukalin1, Megan K Blanksma, T Dimitri Silva, Samuel W Suyehira, Wendy A Harvey, Sara J Heggland, Peter R Craig.   

Abstract

We have synthesized and characterized the new cadmium chelating agent potassium bis(2-hydroxyethyl)aminoethyldithiocarbonate hemihydrate, K[bhexan] x 0.5H2O (2), that is structurally related to the known effective in vivo cadmium chelating agent potassium bis(2-hydroxyethyl)dithiocarbamate, K[bhedtc] (1). The corresponding cadmium complex of 2 differs from di(bis(2-hydroxyethyl)dithiocarbamato)cadmium(II), Cd(bhedtc)2 (3), in that the insoluble compound exhibits an elemental composition consistent with a cadmium:ligand ratio of 2:1. The cytotoxicity of the 1-3 was investigated using the human osteoblast-like cell line, Saos-2. Compounds 1 or 2 did not affect cell adherence or cell viability in the 100-500 microM concentration range studied, whereas 3 resulted in a concentration-dependent increase in loss of cell adherence and decrease in cell viability. Overall, the results of the loss of cell adherence, trypan blue exclusion and MTT assays showed that administration of 3 (cadmium complex of 1) resulted in cytotoxicity lower than that of cadmium chloride, but higher than that of the chelator 1 alone. The effect of simultaneous addition of cadmium chloride and 1 or 2 on cell viability was also assessed using the MTT assay. For the 100 microM cadmium chloride experiments, cell viability comparable to control cells was achieved for both 1 and 2 in the 100-500 microM concentration range studied. Cell viability comparable to control cells was achieved for 1 but not 2 in the 100-500 microM concentration range studied for the 200 microM cadmium chloride experiments. Thus 1 appears more effective than 2 in the ability to mediate the cytotoxic effects of cadmium in vitro upon concomitant administration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16758114     DOI: 10.1007/s10534-006-9015-1

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  3 in total

1.  Cadmium-induced decrease in RUNX2 mRNA expression and recovery by the antioxidant N-acetylcysteine (NAC) in the human osteoblast-like cell line, Saos-2.

Authors:  Spenser S Smith; Jackeline Rodriguez Reyes; Kate S Arbon; Wendy A Harvey; Lindsey M Hunt; Sara J Heggland
Journal:  Toxicol In Vitro       Date:  2008-11-05       Impact factor: 3.500

2.  The growth inhibitory effects of cadmium and copper on the MDA-MB468 human breast cancer cells.

Authors:  Mojtaba Panjehpour; Masih-Allah Taher; Mortaza Bayesteh
Journal:  J Res Med Sci       Date:  2010-09       Impact factor: 1.852

3.  Cadmium-coordinated supramolecule suppresses tumor growth of T-cell leukemia in mice.

Authors:  Xiaoping Zhou; Yukio Koizumi; Muxin Zhang; Miyuki Natsui; Souichi Koyota; Manabu Yamada; Yoshihiko Kondo; Fumio Hamada; Toshihiro Sugiyama
Journal:  Cancer Sci       Date:  2015-04-06       Impact factor: 6.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.